Medibank Pvt Ltd (ASX: MPL) Share Price and News
Price
$4.88
Movement
0.03 (+0.62%)
as at 20 Jun - Closed (20 mins delayed)
52 Week Range
$3.53 - $4.97
1 Year Return
+32.97%
Medibank Pvt Ltd Chart and Price Data
2025
2025
2025
2025
$3
$4
$5
$3
$4
$5
$3
$4
$5
$3
$4
$5
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$13.44 billion
P/E Ratio
27.25
Dividend Yield
3.55%
Shares Outstanding
2.75 billion
Earnings per share
0.178
Dividend per share
0.16
Year To Date Return
30.03%
Earnings Yield
3.67%
Franking
100%
Share Price
$4.88
Day Change
0.03 (+0.62%)
52 Week Range
$3.53 - $4.97
Yesterday's Close
$4.85
Today's Open
$4.83
Days Range
$4.82 - $4.90
Volume
14,844,376
Avg. Volume (1 month)
5,813,293
Turnover
$70,112,721
as at 20 Jun - Closed
Medibank Pvt Ltd (ASX: MPL)
Latest News
Share Gainers
Why Eagers, Medibank, Neuren, and Qantas shares are jumping today
Earnings Results
Medibank share price jumps 7% on strong half-year profit growth
52-Week Highs
8 ASX 300 shares hitting new price highs today
Investing Strategies
ASX on the rise: 2 momentum shares to buy immediately
52-Week Highs
5 ASX 200 stocks hitting new 52-week highs today
Dividend Investing
Which ASX 200 financial share will pay the best dividend yield in 2025?
Healthcare Shares
With a projected 7% dividend yield, is the Medibank share price a buy?
Dividend Investing
Why I think these 2 ASX shares are ideal for income investors
Healthcare Shares
Is Medibank stock a good buy?
Broker Notes
ASX financial shares are up 33% this year. Brokers reveal which stocks to buy for 2025
Cheap Shares
Here are 2 of my favourite cheap ASX shares to buy today
Cheap Shares
Here are 2 cheap Australian shares for the Christmas list
Frequently Asked Questions
-
Medibank Private was established by the Australian government in 1976 as a not-for-profit private health insurer. It converted into a for-profit entity in 2009 before listing on the ASX in November 2014.
-
Yes, Medibank Private has paid dividends to shareholders every year since 2015. Typically, it pays an interim dividend in March and a final dividend in September, both fully franked.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 06 Mar 2025 | $0.0780 | 100.00% | Interim | 26 Mar 2025 |
| 04 Sep 2024 | $0.0940 | 100.00% | Final | 26 Sep 2024 |
| 29 Feb 2024 | $0.0720 | 100.00% | Interim | 20 Mar 2024 |
| 13 Sep 2023 | $0.0830 | 100.00% | Final | 05 Oct 2023 |
| 02 Mar 2023 | $0.0630 | 100.00% | Interim | 22 Mar 2023 |
| 07 Sep 2022 | $0.0730 | 100.00% | Final | 29 Sep 2022 |
| 04 Mar 2022 | $0.0610 | 100.00% | Interim | 24 Mar 2022 |
| 08 Sep 2021 | $0.0690 | 100.00% | Final | 30 Sep 2021 |
| 03 Mar 2021 | $0.0580 | 100.00% | Interim | 25 Mar 2021 |
| 02 Sep 2020 | $0.0630 | 100.00% | Final | 24 Sep 2020 |
| 03 Mar 2020 | $0.0570 | 100.00% | Interim | 26 Mar 2020 |
| 04 Sep 2019 | $0.0740 | 100.00% | Final | 26 Sep 2019 |
| 05 Mar 2019 | $0.0570 | 100.00% | Interim | 28 Mar 2019 |
| 05 Sep 2018 | $0.0720 | 100.00% | Final | 27 Sep 2018 |
| 06 Mar 2018 | $0.0550 | 100.00% | Interim | 28 Mar 2018 |
| 06 Sep 2017 | $0.0000 | 100.00% | Final | 28 Sep 2017 |
| 07 Mar 2017 | $0.0525 | 100.00% | Interim | 29 Mar 2017 |
| 06 Sep 2016 | $0.0600 | 100.00% | Final | 28 Sep 2016 |
| 04 Mar 2016 | $0.0500 | 100.00% | Interim | 29 Mar 2016 |
MPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 20th Jun 2025 2025-06-20T16:26:19 | Change in substantial holding | YesNo | 4:26pm | 3 | 197k |
| 16th May 2025 2025-05-16T16:34:00 | Change in substantial holding | YesNo | 4:34pm | 3 | 202k |
| 16th May 2025 2025-05-16T08:50:32 | FY25 Full Year - Key Dates | YesNo | 8:50am | 1 | 217k |
| 6th May 2025 2025-05-06T08:28:41 | Medibank shares business update and healthcare insights | YesNo | 8:28am | 3 | 232k |
| 4th Apr 2025 2025-04-04T12:45:30 | 2022 cybercrime event - consumer class action | YesNo | 12:45pm | 1 | 187k |
| 3rd Apr 2025 2025-04-03T08:22:43 | Notification of cessation of securities - MPL | YesNo | 8:22am | 4 | 13k |
| 25th Mar 2025 2025-03-25T16:37:19 | Becoming a substantial holder | YesNo | 4:37pm | 6 | 307k |
| 27th Feb 2025 2025-02-27T08:08:25 | HY25 Results - Investor Presentation | YesNo | 8:08am | 37 | 1.8M |
| 27th Feb 2025 2025-02-27T08:08:10 | HY25 Results - Media Release | YesNo | 8:08am | 5 | 167k |
| 27th Feb 2025 2025-02-27T08:07:55 | Dividend/Distribution - MPL | YesNo | 8:07am | 4 | 14k |
About Medibank Pvt Ltd
Previously owned by the Australian government, Medibank Private Ltd (ASX: MPL) is the largest health insurer in Australia.
As of November 2022, its two brands, Medibank Private and ahm, provide cover to almost five million people.
Medibank and Australia's fourth-largest health fund, NIB Holdings Limited (ASX: NIB), are the only health insurers listed on the ASX.
In addition to private health insurance, the company provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
MPL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 19 Jun 2025 | $4.85 | $-0.03 | -0.61% | 5,603,115 | $4.87 | $4.88 | $4.83 |
| 18 Jun 2025 | $4.88 | $-0.02 | -0.41% | 6,243,653 | $4.92 | $4.97 | $4.88 |
| 17 Jun 2025 | $4.90 | $-0.01 | -0.20% | 4,074,863 | $4.90 | $4.93 | $4.90 |
| 16 Jun 2025 | $4.91 | $0.01 | 0.20% | 2,885,406 | $4.91 | $4.93 | $4.90 |
| 13 Jun 2025 | $4.90 | $-0.02 | -0.41% | 4,351,931 | $4.93 | $4.93 | $4.88 |
| 12 Jun 2025 | $4.92 | $0.04 | 0.82% | 5,027,368 | $4.91 | $4.93 | $4.89 |
| 11 Jun 2025 | $4.88 | $-0.02 | -0.41% | 3,930,815 | $4.88 | $4.92 | $4.88 |
| 10 Jun 2025 | $4.90 | $0.05 | 1.03% | 4,091,030 | $4.85 | $4.91 | $4.84 |
| 06 Jun 2025 | $4.85 | $-0.05 | -1.02% | 3,917,625 | $4.92 | $4.95 | $4.84 |
| 05 Jun 2025 | $4.90 | $0.02 | 0.41% | 6,110,210 | $4.86 | $4.90 | $4.85 |
| 04 Jun 2025 | $4.88 | $-0.08 | -1.61% | 7,492,079 | $4.95 | $4.95 | $4.85 |
| 03 Jun 2025 | $4.96 | $0.09 | 1.85% | 8,956,339 | $4.90 | $4.96 | $4.87 |
| 02 Jun 2025 | $4.87 | $0.10 | 2.10% | 5,568,708 | $4.78 | $4.90 | $4.78 |
| 30 May 2025 | $4.77 | $-0.05 | -1.04% | 22,179,123 | $4.79 | $4.83 | $4.76 |
| 29 May 2025 | $4.82 | $0.01 | 0.21% | 3,829,352 | $4.82 | $4.85 | $4.80 |
| 28 May 2025 | $4.81 | $-0.03 | -0.62% | 6,464,544 | $4.83 | $4.85 | $4.79 |
| 27 May 2025 | $4.84 | $0.01 | 0.21% | 4,605,538 | $4.82 | $4.85 | $4.81 |
| 26 May 2025 | $4.83 | $0.01 | 0.21% | 3,593,113 | $4.79 | $4.86 | $4.79 |
| 23 May 2025 | $4.82 | $-0.01 | -0.21% | 2,846,797 | $4.82 | $4.85 | $4.81 |
| 22 May 2025 | $4.83 | $0.01 | 0.21% | 4,484,778 | $4.80 | $4.85 | $4.79 |
| 21 May 2025 | $4.82 | $0.07 | 1.47% | 7,744,030 | $4.80 | $4.83 | $4.76 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Dec 2024 | David Koczkar | Issued | 932,801 | $3,609,939 |
Issue of securities. 2,314,729 Performance Rights
|
| 25 Nov 2024 | David Koczkar | Transfer | 457,907 | $1,712,572 |
As advised by the company. Transfer of 457,907 Ordinary Shares from
David Koczkar to Olive Man Investments Pty Ltd |
| 25 Nov 2024 | David Koczkar | Transfer | 457,907 | $1,712,572 |
As advised by the company. Transfer of 457,907 Ordinary Shares from
David Koczkar to Olive Man Investments Pty Ltd |
| 02 Sep 2024 | David Koczkar | Buy | 457,907 | $1,827,048 |
Conversion of securities.
|
| 02 Sep 2024 | David Koczkar | Expiry | 260,942 | $1,041,158 |
As advised by the company. Lapsed,1,839,835 Rights
|
| 02 Sep 2024 | David Koczkar | Exercise | 457,907 | $1,827,048 |
Conversion of securities. 1,381,928 Rights
|
| 26 Aug 2024 | Kathryn Fagg | Buy | 32,750 | $129,362 |
On-market trade.
|
| 26 Aug 2024 | Jay Weatherill | Buy | 5,100 | $19,915 |
On-market trade.
|
| 26 Aug 2024 | Michael (Mike) Wilkins | Buy | 100,000 | $396,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael (Mike) John Wilkins | Non-Executive DirectorNon-Executive Chairman | May 2017 |
Mr Wilkins has more than 30 years of experience in financial services, predominantly in Australia and Asia. He is a member of Investment and Capital and People Committee.
|
| Mrs Linda Bardo Nicholls | Non-Executive Director | Mar 2014 |
Mrs Nicholls has more than 30 years of experience as a senior executive and director in banking, insurance and funds management in Australia, New Zealand and the United States. She is the Chair of the Investment and Capital Committee and also a member of Risk Management Committee.
|
| Ms Kathryn Joy Fagg | Non-Executive Director | Mar 2022 |
Ms Fagg is a director and Chair with wide-ranging senior commercial and operational experience. She is a member of People Committee.
|
| Mr David Fagan | Non-Executive Director | Mar 2014 |
Mr Fagan has practised as a commercial lawyer for over 40 years. During that time, he held a variety of leadership positions at Clayton Utz culminating in the role of Chief Executive Partner for 9 years. He is the Chair of the Risk Management Committee.
|
| Mr David Koczkar | Chief Executive OfficerManaging Director | May 2021 |
Mr Koczkar has more than 25 years of strategy, innovation, commercial and operational experience across Australia, Asia and the UK, including previous work in the consulting and financial services industries.
|
| Mr Peter Dobie Everingham | Non-Executive Director | Mar 2022 |
Mr Everingham has over 25 years of corporate experience and is highly respected in the digital sector, having held senior executive roles in that sector for 18 years. His senior leadership experience includes key roles at companies with a strong consumer and technology focus. He is a member of People and Investment and Capital Committee.
|
| Dr Tracey Leigh Batten | Non-Executive Director | Aug 2017 |
Dr Batten has experience in the health services sector, with strong commercial, business and change leadership skills. She is the Chair of the People Committee and also a member of Risk Management Committee.
|
| Mr Gerard Dalbosco | Non-Executive Director | May 2021 |
Mr Dalbosco held a number of senior leadership roles including Oceania Managing Partner and CEO; Asia Pacific Joint Deputy CEO and Managing Partner-Markets; Oceania Managing Partner-Transaction Advisory Services; and Melbourne Managing Partner. Prior to these roles Gerard advised organisations across a range of sectors in respect of merger and acquisitions advice, valuations, and strategic, commercial and financial due diligence. He is a member of Risk Management Committee.
|
| Mr Jay Wilson Weatherill | Non-Executive Director | Mar 2024 |
Mr Weatherill has had a career in public office with expertise across a wide range of public policy areas including reform of social services. He is a member of Risk Management Committee.
|
| Ms Mei Ramsay | Group General CounselCompany Secretary | Mar 2011 |
-
|
| Mei Ramsay | Group General CounselCompany Secretary |
-
|
|
| Rob Read | Group Lead Amplar Health |
-
|
|
| Milosh Milisavljevic | Group Lead Chief Customer Officer |
-
|
|
| Mark Rogers | Group Lead Chief Financial Officer & Group Strategy |
-
|
|
| Tom Exton | Group Lead Chief Risk & Compliance Officer |
-
|
|
| Felicia Trewin | Group Lead Data & Technology |
-
|
|
| Rob Deeming | Group Lead Digital & Ventures |
-
|
|
| Kylie Bishop | Group Lead People Spaces & Sustainability |
-
|
|
| Meaghan Telford | Group Lead Policy Advocacy & Reputation |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 897,801,743 | 32.60% |
| J P Morgan Nominees Australia Pty Limited | 542,208,525 | 19.69% |
| Citicorp Nominees Pty Limited | 320,377,977 | 11.63% |
| National Nominees Limited | 81,375,680 | 2.95% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 71,271,047 | 2.59% |
| BNP Paribas Noms Pty Ltd | 46,314,124 | 1.68% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 21,450,620 | 0.78% |
| HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 20,002,248 | 0.73% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 8,980,884 | 0.33% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 7,590,106 | 0.28% |
| HSBC Custody Nominees (Australia) Limited i | 7,343,069 | 0.27% |
| Netwealth Investments Limited <Wrap Services A/C> | 6,630,695 | 0.24% |
| IOOF Investment Services Limited <Ips Superfund A/C> | 5,169,307 | 0.19% |
| UBS Nominees Pty Ltd | 4,975,089 | 0.18% |
| Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 4,961,790 | 0.18% |
| IOOF Investment Services Limited <Iisl Nal Isma 2 A/C> | 3,786,900 | 0.14% |
| Bond Street Custodians Limited <Cockej - F01832 A/C> | 3,784,143 | 0.14% |
| Ioof Investment Services Limited <Ioof Idps A/C> | 3,745,418 | 0.14% |
| Netwealth Investments Limited <Super Services A/C> | 3,279,571 | 0.12% |
| Solium Nominees (Australia) Pty Ltd <Vsa A/C> | 3,221,313 | 0.12% |